Enumeral Biomedical Holdings, Inc.
(Other OTC/NBB : ENUM)

( )
ENUM PreMarket: $ () as of AM
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Health Technology » Biotechnology

Company Profile

Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of novel antibody immunotherapies for the treatment of cancer and other diseases. It uses a human-driven immunoprofiling platform to identify and validate potential drug candidates in human immune microenvironments. The company was founded by Barry C. Buckland, John J. Rydzewski, Arthur H. Tinkelenberg in 2009 and is headquartered in Cambridge, MA.